Microfluidic Mapping of Cancer Cell-Protein Binding Interaction.

Area of Science:

• Cell Biology
• Biophysics
• Cancer Research

Background:

• Tumor cell metastasis involves interactions between cell surface receptors (e.g., integrins) and protein ligands.
• Understanding these interactions is crucial for extracellular matrix (ECM) remodeling and therapeutic target identification.

Purpose of the Study:

• To develop and validate a microfluidic chip for qualitative and quantitative mapping of cell-protein interactions.
• To investigate the binding characteristics of β1 integrin with ECM proteins and fibrinogen.
• To assess the potential of the chip as a platform for drug discovery targeting integrin pathways.

Main Methods:

• Utilized a novel microfluidic chip to analyze interactions between a large population of cells and proteins.
• Quantitatively assessed the binding affinity of β1 integrin to various ECM proteins (e.g., collagen) and plasma fibrinogen.
• Correlated observed cell-protein interactions with cancer cell invasiveness and potential metastatic mechanisms.

Main Results:

• β1 integrin exhibited stronger binding to collagen compared to other ECM proteins.
• Upregulated β1 integrin in invasive cancer cells enhanced cell-ECM interactions, potentially promoting ECM remodeling.
• Cancer cells demonstrated significant interaction with plasma fibrinogen, suggesting a role in vascular arrest during metastasis.

Conclusions:

• The microfluidic chip effectively maps cell-protein interactions, providing insights into metastasis.
• β1 integrin and fibrinogen interactions are key factors in cancer cell adhesion and ECM remodeling.
• The developed chip serves as a valuable platform for discovering drugs targeting integrins and cytoskeletal pathways.